Genelux Corporation (GNLX)
(Delayed Data from NSDQ)
$7.82 USD
+0.11 (1.43%)
Updated Oct 24, 2025 04:00 PM ET
After-Market: $7.77 -0.05 (-0.64%) 4:44 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Genelux Corporation has a market cap of $291.23M, which represents its share price of $7.71 multiplied by its outstanding shares number of 37.77M. As a small-cap company, GNLX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
GNLX 7.82 +0.11(1.43%)
Will GNLX be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for GNLX based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for GNLX
Genelux Corporation (GNLX) Upgraded to Buy: Here's What You Should Know
Is EUROFINS SCIENT (ERFSF) Outperforming Other Medical Stocks This Year?
GNLX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Down -29.7% in 4 Weeks, Here's Why Genelux Corporation (GNLX) Looks Ripe for a Turnaround
Other News for GNLX
Is GNLX gaining bullish strength? New 52 Week Closing High shows up after soaring 22.19%
12 Health Care Stocks Moving In Thursday's Intraday Session
Upper Bollinger Band Walk appears for GNLX after 6.1% move
Genelux Corp: Strong Buy Rating Backed by Promising Olvi-Vec Developments and Sector Momentum
Is GNLX gaining bullish strength? New 52 Week Closing High shows up after gaining 3.23%